Brief: Kezar Life Sciences Reports Second Quarter 2022 Financial Results And Provides Business Update
Aug 11 (Reuters) - Kezar Life Sciences Inc KZR.O :
* KEZAR LIFE SCIENCES REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES TOTALED
$306.8
MILLION AS OF JUNE 30, 2022
* Q2 LOSS PER SHARE $0.25
Source text for Eikon: ID:nBw6Cbsm1a
Further company coverage: KZR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kezar Life Sciences
See all newsNASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
U.S. STOCKS ON THE MOVE-Sysco, Crowdstrike, GM